![Steven D. Reich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven D. Reich
Chief Tech/Sci/R&D Officer at
ARTELO BIOSCIENCES, INC.
Profile
Dr. Steven D.
Reich, MD, is a Chief Medical Officer at Artelo Biosciences, Inc. and a Vice President-Clinical Development at Actuate Therapeutics, Inc. Dr. Reich was previously employed as a Chief Executive & Medical Officer by Anaborex, Inc. He received his graduate degree from the University of Medicine & Dentistry of New Jersey and a doctorate degree from the University of Medicine & Dentistry of New Jersey.
Steven D. Reich active positions
| Companies | Position | Start |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/04/2018 |
| ACTUATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Steven D. Reich
| Companies | Position | End |
|---|---|---|
Anaborex, Inc.
 Anaborex, Inc. Medical/Nursing ServicesHealth Services Provides clinical research services | President | 31/12/2012 |
Training of Steven D. Reich
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Provides clinical research services | Health Services |
Artelo Biosciences, Inc.
 Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
University of Medicine & Dentistry of New Jersey
 University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Steven D. Reich
